456 related articles for article (PubMed ID: 24148899)
1. Eosinophil apoptosis as a therapeutic target in allergic asthma.
Ilmarinen P; Kankaanranta H
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):109-17. PubMed ID: 24148899
[TBL] [Abstract][Full Text] [Related]
2. Delayed eosinophil apoptosis in asthma.
Kankaanranta H; Lindsay MA; Giembycz MA; Zhang X; Moilanen E; Barnes PJ
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):77-83. PubMed ID: 10887309
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Kim SH; Hong JH; Lee YC
Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
[TBL] [Abstract][Full Text] [Related]
4. [Eosinophil apoptosis and asthma].
Dziedziczko A; Pałgan K
Pol Merkur Lekarski; 2004 Jul; 17(97):73-5. PubMed ID: 15559618
[TBL] [Abstract][Full Text] [Related]
5. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.
Noga O; Hanf G; Brachmann I; Klucken AC; Kleine-Tebbe J; Rosseau S; Kunkel G; Suttorp N; Seybold J
J Allergy Clin Immunol; 2006 Jun; 117(6):1493-9. PubMed ID: 16751018
[TBL] [Abstract][Full Text] [Related]
6. [The influence of dexamethasone on mRNA expression of interleukin-5, interleukin-3 and granulocyte-macrophage colony-stimulating factor receptors in eosinophils of guinea pig asthma model].
Li Z; Wang C; Qian G
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Sep; 24(9):542-7. PubMed ID: 11758170
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological regulation of human eosinophil apoptosis.
Kankaanranta H; Moilanen E; Zhang X
Curr Drug Targets Inflamm Allergy; 2005 Aug; 4(4):433-45. PubMed ID: 16101520
[TBL] [Abstract][Full Text] [Related]
8. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
9. Blood eosinophil leukotriene C4 production in asthma of different severities.
Laviolette M; Ferland C; Comtois JF; Champagne K; Bossé M; Boulet LP
Eur Respir J; 1995 Sep; 8(9):1465-72. PubMed ID: 8575570
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis.
Alam R; Forsythe P; Stafford S; Fukuda Y
J Exp Med; 1994 Mar; 179(3):1041-5. PubMed ID: 8113672
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids inhibit cytokine-mediated eosinophil survival.
Wallen N; Kita H; Weiler D; Gleich GJ
J Immunol; 1991 Nov; 147(10):3490-5. PubMed ID: 1940348
[TBL] [Abstract][Full Text] [Related]
12. Expression of eosinophil β chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma.
Kalinauskaite-Zukauske V; Januskevicius A; Janulaityte I; Miliauskas S; Malakauskas K
BMC Pulm Med; 2019 Aug; 19(1):158. PubMed ID: 31438916
[TBL] [Abstract][Full Text] [Related]
13. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
[TBL] [Abstract][Full Text] [Related]
14. Targeting of eosinophils in asthma.
Molfino NA
Expert Opin Biol Ther; 2012 Jul; 12(7):807-9. PubMed ID: 22500988
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB
Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
[TBL] [Abstract][Full Text] [Related]
16. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3.
Humbert M; Ying S; Corrigan C; Menz G; Barkans J; Pfister R; Meng Q; Van Damme J; Opdenakker G; Durham SR; Kay AB
Am J Respir Cell Mol Biol; 1997 Jan; 16(1):1-8. PubMed ID: 8998072
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions.
Robinson AJ; Kashanin D; O'Dowd F; Fitzgerald K; Williams V; Walsh GM
Clin Exp Allergy; 2009 Dec; 39(12):1866-74. PubMed ID: 19689459
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation.
Hoontrakoon R; Chu HW; Gardai SJ; Wenzel SE; McDonald P; Fadok VA; Henson PM; Bratton DL
Am J Respir Cell Mol Biol; 2002 Apr; 26(4):404-12. PubMed ID: 11919076
[TBL] [Abstract][Full Text] [Related]
19. Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils.
Okada S; Hagan JB; Kato M; Bankers-Fulbright JL; Hunt LW; Gleich GJ; Kita H
J Immunol; 1998 Apr; 160(8):4010-7. PubMed ID: 9558110
[TBL] [Abstract][Full Text] [Related]
20. Effects of saiboku-to on the survival of human eosinophils.
Tohda Y; Haraguchi R; Kubo H; Muraki M; Fukuoka M; Nakajima S
Methods Find Exp Clin Pharmacol; 1999 Jun; 21(5):327-30. PubMed ID: 10420387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
